The generics landscape is being transformed.

The best way to deal with evolving rules, emerging opportunities and upcoming threats is to be in the forefront of updates and impending game changing strategies. Are you on top of it all?

The 5th Annual Generics Asia summit is THE meeting place for C-level decision makers from generics companies, innovator pharma companies, payers, investors, regulators and health authorities to discuss business strategy and to form partnerships in an evolving industry landscape.

Be part of the only conference in Asia focused on generics strategies. Join thought-leaders, health authorities, decision makers from major generics companies and innovators from Indonesia, China, Philippines, Japan, Malaysia, India, Australia, Singapore, Israel, USA and Europe as they gather to map the industry’s rise and future:

Whether you are looking after strategy for a Generics company or looking out for business opportunities from an innovator company, the 5th Generics Asia Summit is the place to be at.

Take advantage of this informative and thought-provoking meeting.

Why You Can’t Afford to Miss this Event:     Gain unique insights into “Game changing” developments in the generics industry Hear the latest updates and initiatives by “big pharma” Anticipate growth strategies and funding/investment sources Understand and implement generics branding, sales and market entry campaigns Overview of evolving regulatory updates, compliance and approvals in developed and emerging markets Discuss upcoming challenges in manufacturing, safety and distribution Explore biosimilars/biobetters and emerging opportunities for Branded / Supergenerics Distinguished Panel of Speakers including:     Tim Oldham President Asia Pacific, Hospira, Australia Dr Branimir Brankov Senior Director, Strategic Business Intelligence, Merck and Co, USA Vijay Karwal Managing Director, Royal Bank of Scotland, Hong Kong Alan Sheppard Global Head of Generics, Thought Leadership, IMS Health, UK Uros Urleb Chief Scientific Officer, Sandoz, Germany Thomas Runkel Vice President, Asia/Pacific, Actavis, Indonesia Jose Maria A Ochave Corporate Vice President Business Development & Legal, United Laboratories, Philippines Venkatesh Srinivasan Director Strategy and Business Development, Pfizer, India KV Subramaniam President and CEO, Reliance Life Sciences, India Rustom Mody Chief Scientific Officer, Intas Biopharmacueticals, India Dr Sushrut Bhatt Medical and Clinical Research, GlaxoSmithKline Pharmaceuticals, India Dr Yuen Kah Hay Director R&D, Hovid Pharmaceuticals, Malaysia View our full speaker list » Who can you expect to meet at Generics 2010

Testimonials     "Well organized with interesting & timely topics. Speaker very knowledgeable. Excellent networking. A must attend event." Sanofi Pasteur "I was pleased with people I met and heard from." JCR Pharmaceuticals "Not only was the program and presentations sensational, but the delegates were high level and I made a deal before the first day closed." Technology Catalyst "Excellent event. High powered speakers. Fantastic networking event." Steine "It was very helpful to understand biosimilar business." Hanwha